Alyeska Investment Group’s Biocept, Inc. BIOC Stock Holding History

Alyeska Investment Group’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-117,647	Closed	-$147K	–	700
2023 Q3	$147K	Buy	+117,647	New	+$142K	﹤0.01%	466

Alyeska Investment Group's BIOC Position: Q4 2023 in Review

Alyeska Investment Group sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 117,647 shares — an estimated $147K sold.

Alyeska Investment Group first reported a position in BIOC in Q3 2023 and held it in 1 quarter. The position peaked at $147K in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

Alyeska Investment Group reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
Alyeska Investment Group sold 117,647 Biocept, Inc. shares in Q4 2023, an estimated $147K.
Alyeska Investment Group first reported a position in Biocept, Inc. in Q3 2023 and held it in 1 quarter.
Alyeska Investment Group's Biocept, Inc. position peaked at $147K in Q3 2023.
0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.